Clover Health CLOV
Revenue per employee
724 employees as of 2025/FY (+27.0% YoY). Revenue per employee is total revenue divided by headcount — a rough productivity gauge, not a per-worker pay figure.
Management team
Background
Jamie L. Reynoso. Jamie L. Reynoso is our Chief Executive Officer of Medicare Advantage, a position she has held since January 2023. Previously she served as our Chief Operating Officer from July 2020 to January 2023. Before joining Clover Health, from April 2016 to December 2019, Ms. Reynoso served as Chief Operating Officer and then Chief Executive Officer of Memorial Hermann Health Plan, a provider-sponsored health plan. From November 2012 to April 2016, she served as Regional Vice President of Payer Strategy and Operations with Catholic Health Initiatives, a large national hospital system. Prior to that, she spent over 16 years at UnitedHealth Group, where she held various roles including Vice President of Emerging Business. Ms. Reynoso holds a B.B.A. from Texas A&M University-Kingsville.
Background
Andrew Toy. Andrew Toy has served as our Chief Executive Officer since January 1, 2023, and as a member of our Board of Directors since November 2018. Prior to becoming Chief Executive Officer, he had served as our President since March 2019. He previously also served as our Chief Technology Officer from February 2018 to February 2022. Prior to joining Clover Health, from May 2014 to February 2018, Mr. Toy was at Google LLC, a multinational technology company. He worked on the Google Cloud team where he was responsible for Developer Platform and Intelligence features, and led Android for Work, the enterprise platform for Android. Mr. Toy joined Google as a result of the May 2014 acquisition of Divide, a company focused on creating a split between work and personal data on mobile devices From January 2010 through its acquisition, Mr. Toy was the Chief Executive Officer, a director and co-founder of Divide. Mr. Toy holds a B.S. and an M.S. in computer science from Stanford University, where he has also served as an associate lecturer from June 2000 to April 2001.
Background
Conrad Wai is the Chief Executive Officer of Counterpart Health, Inc., our wholly-owned subsidiary focused on our software-as-a-service and tech enabled services solution to bring the power of Clover Assistant technology to external payors and providers serving the Medicare eligible population. Mr. Wai has held this position since September 2024. Prior to becoming CEO of Counterpart Health, Inc., Mr. Wai served as our Chief Technology Officer since February 2022. Prior to joining Clover, Mr. Wai was the Senior Vice President of Product at Hinge Health, a digital health startup, from February 2021 to September 2021 and the Vice President of Product and Design from March 2019 to January 2021. He served in product management roles at Yahoo from 2014 to 2017 and then as Operating Vice President of Product Management at Verizon Media from 2017 to 2018 after Yahoo was acquired by Verizon Media during his tenure. Mr. Wai holds both a B.S. and M.S. in computer science from Stanford University.
Background
Demetrios L. Kouzoukas. Demetrios L. Kouzoukas has served as a member of our Board of Directors since April 2021. Since April 2022, he has served as a Partner and Principal of Team8 Partners, a venture capital firm focused on cybersecurity, data, fintech and healthcare. Prior to joining our Board, from February 2017 until January 2021, Mr. Kouzoukas served as the Director of the Center for Medicare and the Principal Deputy Administrator of the Centers for Medicare and Medicaid Services. Previously, from 2012 to 2016, Mr. Kouzoukas served as General Counsel of the Medicare and Retirement business of UnitedHealthcare, a health insurance company. From 2003 to 2009, Mr. Kouzoukas was Principal Associate Deputy Secretary of the U.S. Department of Health and Human Services (HHS), with responsibility for regulatory policy across HHS, and Deputy General Counsel. In 2014, Mr. Kouzoukas was appointed a Public Member of the Administrative Conference of the United States. Mr. Kouzoukas holds a B.A. in political science and public policy from the George Washington University and a J.D. from the University of Illinois College of Law.
Background
William G. Robinson, Jr. William G. Robinson, Jr. has served as a member of our Board of Directors since March 2021. Mr. Robinson has served as the President of Broadgate Human Capital, LLC, a management consulting firm, since October 2018. Prior to Broadgate, Mr. Robinson served as the Executive Vice President and Chief Human Resources Officer for Sabre Corporation, a travel technology company, from December 2013 to September 2017. Prior to Sabre, Mr. Robinson served as the Senior Vice President and Chief Human Resources Officer at Coventry Health Care, a diversified managed health care company, from 2012 to 2013. From 2010 to 2011, Mr. Robinson served as Senior Vice President of human resources at Outcomes Health Information Solutions, a healthcare analytics and information company specializing in the optimization and acquisition of medical records. Prior to that, from 1990 to 2010, he worked for General Electric, where he held several human resources leadership roles in diverse industries, including information technology, healthcare, energy, security and industrial. Mr. Robinson formerly served as a member of the board of directors of American Public Education, Inc. and as a member of the board of trustees for the American Public University System. Mr. Robinson holds a B.A. in communications from Wake Forest University and an M.A. in human resources from Bowie State University.
Background
Anna U. Loengard, M.D. Dr. Anna U. Loengard has served on our Board of Directors since November 2022. Since December 2022, Dr. Loengard has served as President of Successful Caring LLC, which provides strategic clinical consulting to clients such as Oxeon Venture Studios, Rubicon Founders and Curana Health. From August 2020 to October 2022, Dr. Loengard served as the Chief Medical Officer of AccentCare, an enterprise providing home health, hospice and private care services. Previously, Dr. Loengard served as the Chief Medical Officer for Caravan Health from July 2017 to June 2020; the Chief Medical Officer for the Queen's Healthcare System's Clinically Integrated Physician Network from October 2014 to June 2017, and the Chief Medical Officer at St. Francis Healthcare System from February 2011 to February 2014, focusing on post-acute care. She received her M.D. from the State University of New York at Stony Brook and completed her residency in Internal Medicine at Harvard Medical School, Beth Israel Deaconess Medical Center, and her Geriatrics Fellowship at the University of Arizona.
Background
Thomas L. Tran. Thomas L. Tran has served as a member of our Board of Directors since August 2024. Mr. Tran has over 35 years of financial leadership experience in the healthcare industry and has previously held leadership roles at various prominent managed care companies. Most recently, since March 2025, Mr. Tran has served as a director Guidehealth LLC, a private healthcare company servicing the health systems and clinical networks in the areas of third party administration and value-based care. Since September 2023, Mr. Tran has served as a member of the Board of Regents of Seton Hall University. From February 2022 to June 2023, Mr. Tran served as chief financial officer and as a director of Upstream Care, a value-based physician enablement innovator focused on the Medicare population. Since March 2021, he has served as an advisor to Gryphon Investors, a private equity firm. From June 2018 to May 2021, he served as chief financial officer of Molina Healthcare, Inc. Mr. Tran earned his Bachelor's degree from Seton Hall University and his Master of Business Administration degree from New York University.
Background
Carladenise Armbrister Edwards, Ph.D. Carladenise Armbrister Edwards has served as a member of our Board of Directors since July 2022. Since August 2023, Dr. Edwards has served as Miami-Dade County's Chief Administrative Officer responsible for overseeing the County's annual operating budget and managing the Departments of Office of Management and Budget (OMB) in addition to its other operating functions. From July 2020 to August 2022, Dr. Edwards served as the Executive Vice President and Chief Strategy Officer of the Henry Ford Health System, where she led the system's strategic planning efforts and partnership ventures, business development and transformation initiatives, government affairs strategy, as well as Henry Ford Innovations. Prior to Henry Ford, Dr. Edwards was Executive Vice President and Chief Strategy Officer for Providence St. Joseph Health, a health system, from July 2018 to June 2020, and the Senior Vice President, Contracting for Providence St. Joseph Health from January 2017 to July 2018. Dr. Edwards' experience includes several additional executive leadership roles, including Chief Administrative Officer for Providence Health & Services' Population Health division and Chief Strategy Officer for Alameda Health System. Dr. Edwards also served as Founding President and Chief Executive Officer of Cal eConnect, Inc., a nonprofit corporation that governed California's electronic Health Information Exchange. Additionally, she served as Chief of Staff and Interim Commissioner for Georgia's Department of Community Health. Dr. Edwards holds a Ph.D. in Medical Sociology from the University of Florida, a master's degree in education and psychological services and a bachelor's degree in sociology from the University of Pennsylvania.
Background
On March 30, 2026, the board of directors of Clover Health Investments, Corp. appointed Mr. Clay Thornton as the Interim Chief Financial Officer of the Company. Mr. Thornton, the current Chief Financial Officer of Clover Insurance Company, will also be serving as the Company's principal financial officer. Mr. Thornton, age 36, has served in his current role at the Company since February 2024. Prior to that, Mr. Thornton served as Vice President, Venture and PE Finance at Hunsicker from January 2023 to February 2024. From January 2022 to December 2022, Mr. Thornton served in financial services for Venture & PE Backed Companies at Venture First. From July 2021 to December 2021, Mr. Thornton served as Vice President - Strategy for Honest Health. Previously, Mr. Thornton served in various financial and leadership positions at Humana Inc. from May 2012 to February 2021. Mr. Thornton received a Bachelor's Degree in Finance and Economics from the University of Kentucky and a Master of Business Administration from the University of Louisville. On November 2, 2026, the Board of Directors of the Company appointed Joseph Clay Thornton, age 37, the Company's Interim Chief Financial Officer and principal financial officer, to serve as the Company's Chief Financial Officer
Background
Mr. Joseph (Joe) Oldakowski, Vice President of Finance and Controller of the Company, was appointed by the Board to serve as the Company's principal accounting officer, effective immediately on March 30 2026. Mr. Oldakowski, age 43, has served in his current role at the Company since July 2025, having joined the Company the previous month. Prior to that, Mr. Oldakowski served as Vice President and Corporate Controller at Point32Health from September 2021 to June 2025. Previously, Mr. Oldakowski was employed by EmblemHealth from May 2017 to September 2021, where he served as Corporate Controller and held progressive leadership roles at The Hartford (November 2015 - May 2017 and September 2008 - March 2014) and MassMutual (March 2014-November 2015). He holds a Master's Degree in Accounting and Taxation from the University of Hartford and a Bachelor's Degree in Accountancy from Bentley University. On November 2, 2026, the Board of Directors of the Company appointed Joseph Frank Oldakowski, age 44, the Company's Vice President, Controller and principal accounting officer, to serve as the Company's Chief Accounting Officer.
Background
Sen. Robert G. Torricelli was appointed to the board of directors as a member with effect from 22nd September 2026. Senator Torricelli is the founder of Rosemont Associates, a business strategy firm founded in 2002, and a founder and partner of Woodrose Properties, a real estate development firm founded in 2003. He served as executive vice president and chief operating officer of Aveta, Inc., a healthcare services company, from March 2007 to February 2012, has served as a director of Glassbridge Enterprises, Inc. since February 2017, and has served on the board of the Company's insurance subsidiaries since 2022, providing firsthand familiarity with Clover's business, mission, and approach to Medicare Advantage. Senator Torricelli represented New Jersey in the U.S. House of Representatives from 1983 to 1997 and in the U.S. Senate from 1997 to 2003, where his committee service included the Senate Finance Committee and work on federal financing for healthcare institutions. He holds a B.A. and J.D. from Rutgers University and a Master of Public Administration from Harvard University. His experience in public policy, healthcare, and business brings a valuable perspective to Clover's Board and Audit Committee.
Background
Dr. Brian J. Miller, M.D., M.B.A., M.P.H. was appointed to the board of directors with effect from 22nd September 2026. Dr. Miller has extensive experience in clinical medicine, healthcare policy, regulation, and health plan governance. Since September 2020, he has served as an Associate Professor of Medicine and Business (Courtesy) at Johns Hopkins University and practiced as a hospitalist at Johns Hopkins Hospital. He joined the Hoover Institution as a Visiting Fellow in March 2026 and currently serves on the Medicare Payment Advisory Commission (MedPAC), the independent, nonpartisan commission that advises Congress on Medicare payment policy, having been appointed in May 2023. He has also served on the Board of Trustees of the North Carolina State Health Plan since January 2025 and became its Vice Chairman in April 2026. Earlier, Dr. Miller held policy and regulatory roles at the Centers for Medicare & Medicaid Services, the U.S. Food and Drug Administration, the Federal Communications Commission, and the Federal Trade Commission. Board-certified in internal medicine and preventive medicine, he brings a practical perspective on improving care delivery and advancing a more effective Medicare program. He holds an M.D. from Northwestern University, an M.B.A. from the University of North Carolina at Chapel Hill, and an M.P.H. from Johns Hopkins University.
Background
Dr. Brian J. Miller, M.D., M.B.A., M.P.H. was appointed to the board of directors with effect from 22nd September 2026. Dr. Miller has extensive experience in clinical medicine, healthcare policy, regulation, and health plan governance. Since September 2020, he has served as an Associate Professor of Medicine and Business (Courtesy) at Johns Hopkins University and practiced as a hospitalist at Johns Hopkins Hospital. He joined the Hoover Institution as a Visiting Fellow in March 2026 and currently serves on the Medicare Payment Advisory Commission (MedPAC), the independent, nonpartisan commission that advises Congress on Medicare payment policy, having been appointed in May 2023. He has also served on the Board of Trustees of the North Carolina State Health Plan since January 2025 and became its Vice Chairman in April 2026. Earlier, Dr. Miller held policy and regulatory roles at the Centers for Medicare & Medicaid Services, the U.S. Food and Drug Administration, the Federal Communications Commission, and the Federal Trade Commission. Board-certified in internal medicine and preventive medicine, he brings a practical perspective on improving care delivery and advancing a more effective Medicare program. He holds an M.D. from Northwestern University, an M.B.A. from the University of North Carolina at Chapel Hill, and an M.P.H. from Johns Hopkins University.
Background
Vivek Garipalli. Vivek Garipalli co-founded Clover Health in 2014 and served as our Chief Executive Officer from July 2014 to December 2022. He has been a member of our Board of Directors since July 2014 and was appointed Executive Chairperson of the Board effective as of January 1, 2023. Mr. Garipalli also served as our President from July 2014 to March 2019. Prior to Clover Health, Mr. Garipalli co-founded both CarePoint Health and Ensemble Health. He served as Co-Founder and Board Member from 2008 to 2022 at CarePoint, a healthcare system that offers acute care and emergency services to a large, historically underserved population. He served as Co-Founder and Board Member from 2014 to 2016 at Ensemble Health, a national healthcare revenue cycle services company. At Flatiron Health, Mr. Garipalli entered as an early investor and advised on its strategy and business model, including leading the acquisition of its data platform, Altos. He subsequently served on Flatiron Health's board from 2012 through its sale to Roche in 2018. He has also previously served or is currently serving on the boards of Cityblock Health, Doctor Evidence, Medically Home, Thyme Care and Swiftly Systems Inc. Mr. Garipalli began his career in finance, holding roles at Credit Suisse First Boston, J.P. Morgan Partners and Blackstone Group. Wormhole Capital, the investment arm of Mr. Garipalli's family office, partners with special founders with the aptitude to build transformative, category-defining companies. Mr. Garipalli holds a B.B.A. in entrepreneurship from Emory University.
Background
Karen Soares is our General Counsel and Corporate Secretary, a position she has held since April 2026. Prior to her appointment as CLO, Ms. Soares was General Counsel of the Company beginning in October 2023. From September 2018 to October 2023 she served in various other roles within Clover Health's legal department. Before joining Clover Health, from October 2012 to August 2018, Ms. Soares served as the General Counsel and Chief Compliance Officer of Analyte Health, a telehealth startup. From October 2005 to September 2012, she was an associate at Fried, Frank, Harris, Shriver & Jacobson LLP, an international law firm. Ms. Soares holds a B.A. from Dartmouth College and a J.D. from the University of Chicago Law School.
From SEC filings, via Futu. Compensation is total reported pay for the most recent fiscal year on file, not base salary alone.
No comments yet — be the first to weigh in on CLOV.
Sign in to join the discussion.